Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mimedx (MDXG) Other Non Operating Income (2016 - 2026)

Mimedx's Other Non Operating Income history spans 12 years, with the latest figure at -$168000.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 15.86% to -$168000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$581000.0, a 4.91% increase, with the full-year FY2025 number at -$558000.0, up 1.24% from a year prior.
  • Other Non Operating Income hit -$168000.0 in Q1 2026 for Mimedx, up from -$186000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for MDXG hit a ceiling of $16000.0 in Q4 2023 and a floor of -$237000.0 in Q2 2024.
  • Historically, Other Non Operating Income has averaged -$94214.3 across 5 years, with a median of -$100000.0 in 2024.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 633.33% in 2023 and later crashed 5050.0% in 2024.
  • Tracing MDXG's Other Non Operating Income over 5 years: stood at -$3000.0 in 2022, then skyrocketed by 633.33% to $16000.0 in 2023, then plummeted by 1400.0% to -$208000.0 in 2024, then rose by 10.58% to -$186000.0 in 2025, then grew by 9.68% to -$168000.0 in 2026.
  • Business Quant data shows Other Non Operating Income for MDXG at -$168000.0 in Q1 2026, -$186000.0 in Q4 2025, and -$126000.0 in Q3 2025.